Comprehensive assessment of patients with fibromyalgia involves more than a physical examination. Treatment of fibromyalgia requires a multidimensional approach that addresses patient symptoms, as well as psychosocial, behavioral, and physical factors, a panel of experts said at the American Pain Society’s 30th Annual Scientific Meeting.
Initial analysis of the effects of duloxetine vs. placebo in patients with chronic low back pain indicates duloxetine has both brain and behavioral effects in this population, Kevin A. Johnson, of Stanford University School of Medicine, Palo Alto, CA, and colleagues reported during the American Pain Society’s 30th Annual Scientific Meeting.
Sodium oxybate was shown to be effective in patients with both moderate to severe fibromyalgia symptoms, according to an analysis presented at the American Pain Society’s 30th Annual Scientific Meeting.
A multicenter pediatric pain clinical trials consortium will facilitate better study design and ensure children experience no additional burden for participation in research, including enduring even slightly undertreated pain, a panel of pediatric pain experts said during the American Pain Society’s 30th Annual Scientific Meeting.
Sublingual fentanyl tablets were generally well tolerated in patients with cancer-related breakthrough pain aged 65 years and older in conjunction with around-the-clock opioid treatment, investigators reported during the American Pain Society’s 30th Annual Scientific Meeting.
Methylnaltrexone bromide, a selective peripherally acting mu-opioid receptor antagonist, is effective for the long-term treatment of opioid-induced constipation resulting from chronic opioid therapy in chronic non-cancer pain, as demonstrated by study data presented at the American Pain Society’s 30th Annual Scientific Meeting.
Argument in the literature exists over interlaminar (IL) versus transforminal (TF) lumbar epidural steroid injection technique as the most effective therapy in lumbar radiculopathy. However, all studies to date have been retrospective, as reported in a presentation at the American Pain Society’s 30th Annual Scientific Meeting.
Fentanyl sublingual spray was significantly more effective at relieving breakthrough cancer pain at 30 minutes compared with placebo. That’s the conclusion of a randomized, double-blind, placebo-controlled, Phase 3 study that was presented during the American Pain Society’s 30th Annual Scientific Meeting.
At the American Pain Society’s 30th Annual Scientific Meeting, study data presented demonstrated that low-dose intrathecal morphine improves both Numeric Pain Rating Scale (NPS) scores and Multidimensional Pain Inventory (MPI) scores in patients with chronic non-cancer pain.
Study data was presented at the American Pain Society’s 30th Annual Scientific Meeting indicated that a noninvasive, preprogrammed method of patient-controlled analgesia (PCA) is effective in treating both major orthopedic and abdominal post-operative pain with minimal adverse events.
Please login or register first to view this content.
